A Pattern of Aggressive Expansion
This multi-billion-dollar deal with IGI comes just days after AbbVie announced another significant investment — a $2.1 billion acquisition of Capstain Therapeutics Inc., a developer of next-generation cell therapies. Together, these moves paint a picture of a company on a mission to dominate the next wave of oncology innovations.
The Legal Minds Behind the Agreement
IGI was represented by Covington & Burling LLP, with key roles played by partners J.D. Weinberg, Van Ellis, and Winsome Cheung. AbbVie’s legal counsel has not yet been disclosed.
